Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Genetic Disorders Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Genetic Disorders Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Cystic Fibrosis (CF)
      • 1.3.3 Duchenne Muscular Dystrophy (DMD)
      • 1.3.4 Lysosomal Storage Disease (LSD)
      • 1.3.5 Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • 1.4 Market Segment by Application
      • 1.4.1 Global Genetic Disorders Drug Market Share by Application (2019-2025)
      • 1.4.2 Clinic
      • 1.4.3 Hospital
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Genetic Disorders Drug Market Size
      • 2.1.1 Global Genetic Disorders Drug Revenue 2014-2025
      • 2.1.2 Global Genetic Disorders Drug Sales 2014-2025
    • 2.2 Genetic Disorders Drug Growth Rate by Regions
      • 2.2.1 Global Genetic Disorders Drug Sales by Regions 2014-2019
      • 2.2.2 Global Genetic Disorders Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Genetic Disorders Drug Sales by Manufacturers
      • 3.1.1 Genetic Disorders Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Genetic Disorders Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Genetic Disorders Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Genetic Disorders Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Genetic Disorders Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Genetic Disorders Drug Price by Manufacturers
    • 3.4 Key Manufacturers Genetic Disorders Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Genetic Disorders Drug Market
    • 3.6 Key Manufacturers Genetic Disorders Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Cystic Fibrosis (CF) Sales and Revenue (2014-2019)
      • 4.1.2 Duchenne Muscular Dystrophy (DMD) Sales and Revenue (2014-2019)
      • 4.1.3 Lysosomal Storage Disease (LSD) Sales and Revenue (2014-2019)
      • 4.1.4 Paroxysmal Nocturnal Hemoglobinuria (PNH) Sales and Revenue (2014-2019)
    • 4.2 Global Genetic Disorders Drug Sales Market Share by Type
    • 4.3 Global Genetic Disorders Drug Revenue Market Share by Type
    • 4.4 Genetic Disorders Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Genetic Disorders Drug Sales by Application

    6 United States

    • 6.1 United States Genetic Disorders Drug Breakdown Data by Company
    • 6.2 United States Genetic Disorders Drug Breakdown Data by Type
    • 6.3 United States Genetic Disorders Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Genetic Disorders Drug Breakdown Data by Company
    • 7.2 European Union Genetic Disorders Drug Breakdown Data by Type
    • 7.3 European Union Genetic Disorders Drug Breakdown Data by Application

    8 China

    • 8.1 China Genetic Disorders Drug Breakdown Data by Company
    • 8.2 China Genetic Disorders Drug Breakdown Data by Type
    • 8.3 China Genetic Disorders Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Genetic Disorders Drug Breakdown Data by Company
    • 9.2 Rest of World Genetic Disorders Drug Breakdown Data by Type
    • 9.3 Rest of World Genetic Disorders Drug Breakdown Data by Application
    • 9.4 Rest of World Genetic Disorders Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Genetic Disorders Drug Sales by Countries
      • 9.4.2 Rest of World Genetic Disorders Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Sanofi
      • 10.1.1 Sanofi Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Genetic Disorders Drug
      • 10.1.4 Genetic Disorders Drug Product Introduction
      • 10.1.5 Sanofi Recent Development
    • 10.2 Vertex
      • 10.2.1 Vertex Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Genetic Disorders Drug
      • 10.2.4 Genetic Disorders Drug Product Introduction
      • 10.2.5 Vertex Recent Development
    • 10.3 Shire
      • 10.3.1 Shire Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Genetic Disorders Drug
      • 10.3.4 Genetic Disorders Drug Product Introduction
      • 10.3.5 Shire Recent Development
    • 10.4 Amgen
      • 10.4.1 Amgen Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Genetic Disorders Drug
      • 10.4.4 Genetic Disorders Drug Product Introduction
      • 10.4.5 Amgen Recent Development
    • 10.5 GW Pharmaceuticals
      • 10.5.1 GW Pharmaceuticals Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Genetic Disorders Drug
      • 10.5.4 Genetic Disorders Drug Product Introduction
      • 10.5.5 GW Pharmaceuticals Recent Development
    • 10.6 Pfizer
      • 10.6.1 Pfizer Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Genetic Disorders Drug
      • 10.6.4 Genetic Disorders Drug Product Introduction
      • 10.6.5 Pfizer Recent Development
    • 10.7 BioMarin
      • 10.7.1 BioMarin Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Genetic Disorders Drug
      • 10.7.4 Genetic Disorders Drug Product Introduction
      • 10.7.5 BioMarin Recent Development
    • 10.8 Sarepta
      • 10.8.1 Sarepta Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Genetic Disorders Drug
      • 10.8.4 Genetic Disorders Drug Product Introduction
      • 10.8.5 Sarepta Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Genetic Disorders Drug Sales Channels
      • 11.2.2 Genetic Disorders Drug Distributors
    • 11.3 Genetic Disorders Drug Customers

    12 Market Forecast

    • 12.1 Global Genetic Disorders Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Genetic Disorders Drug Sales Forecast by Type
    • 12.3 Global Genetic Disorders Drug Sales Forecast by Application
    • 12.4 Genetic Disorders Drug Forecast by Regions
      • 12.4.1 Global Genetic Disorders Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Genetic Disorders Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Genetic Disorders Drug is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Genetic Disorders Drug.

      This report studies the global market size of Genetic Disorders Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Genetic Disorders Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Sanofi
      Vertex
      Shire
      Amgen
      GW Pharmaceuticals
      Pfizer
      BioMarin
      Sarepta

      Market Segment by Product Type
      Cystic Fibrosis (CF)
      Duchenne Muscular Dystrophy (DMD)
      Lysosomal Storage Disease (LSD)
      Paroxysmal Nocturnal Hemoglobinuria (PNH)

      Market Segment by Application
      Clinic
      Hospital

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Genetic Disorders Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Genetic Disorders Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Genetic Disorders Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now